Nitric oxide plasma concentration associated with cognitive impairment in patients with recurrent depressive disorder

被引:64
|
作者
Talarowska, Monika [1 ]
Galecki, Piotr [1 ]
Maes, Michael [2 ]
Orzechowska, Agata [1 ]
Chamielec, Marcelina [1 ]
Bartosz, Grzegorz [3 ,4 ]
Kowalczyk, Edward [5 ]
机构
[1] Med Univ Lodz, Dept Adult Psychiat, PL-91229 Lodz, Poland
[2] Piyavate Hosp, Maes Clin TRIA, Bangkok 10310, Thailand
[3] Med Univ Lodz, Dept Mol Biophys, PL-91229 Lodz, Poland
[4] Univ Rzeszow, Dept Biochem & Cell Biol, Rzeszow, Poland
[5] Med Univ Lodz, Dept Pharmacol & Toxicol, PL-91229 Lodz, Poland
关键词
Depression; Nitric oxide; Cognitive impairment; OXIDATIVE STRESS; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; SPATIAL MEMORY; HOMOCYSTEINE; DEMENTIA; DECLINE; INTERFERENCE; METABOLITES; EXPRESSION;
D O I
10.1016/j.neulet.2012.01.018
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background/aim: Depressive disorders are multifactorial diseases, in which cognitive impairment is one of the characteristic feature. One of the molecules that regulate of various cognitive, emotional and behavioural processes is nitric oxide (NO), synthesized from L-arginine by a family of isoformic enzymes known as nitric oxide synthases (NOS). NO is a gaseous compounds that acts as a biological second messenger in a number of organ system. In addition, NO is a ubiquitous free radical ((NO)-N-center dot) that affects many normal physiologic functions but is also implicated in the etiology and progression of many diseases. The aim of the study was to determine the concentration of NO in patients with recurrent depressive disorder (rDD) and to define relationship between plasma NO levels and the cognitive performance. Methods: The study comprised 78 subjects: patients with rDD (n = 45), healthy controls (CG, n = 33). Cognitive function assessment was based on: TMT, The Stroop Test, VFT, AVLT. Results: Statistically significant differences were found among patients with rDD in the intensity of depression symptoms, measured by the HORS on therapy onset vs. the examination results after 8 weeks of treatment (p < 0.001). The level of NO was substantially higher in patients with rDD compared to CG. For all examined subjects (p < 0.001), elevated levels of NO in blood plasma adversely affect the efficiency of visual-spatial and auditory-verbal working memory as well as short-term declarative memory. For rDD patients, elevated NO levels were associated with worse cognitive test performance. The higher was the concentration of plasma NO, the greater was the severity of depressive symptoms measured by HDRS (p = 0.03). Conclusions: (1) Higher concentration of plasma NO in rDD patients is associated with the severity of depressive symptoms. (2) Elevated levels of plasma NO are related to impairment of visual-spatial and auditory-verbal working memory as well as to impairment of short-term declarative memory. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:127 / 131
页数:5
相关论文
共 50 条
  • [1] Oxidative stress and cognitive impairment in patients with recurrent depressive disorder
    Talarowska, M.
    Galecki, P.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S227 - S227
  • [2] Cognitive impairment in patients with depressive disorder
    Fedorova, S.
    Bartecek, R.
    [J]. EUROPEAN PSYCHIATRY, 2019, 56 : S375 - S375
  • [3] An inducible nitric oxide synthase polymorphism is associated with the risk of recurrent depressive disorder
    Galecki, Piotr
    Maes, Michael
    Florkowski, Antoni
    Lewinski, Andrzej
    Galecka, Elzbieta
    Bienkiewicz, Malgorzata
    Szemraj, Janusz
    [J]. NEUROSCIENCE LETTERS, 2010, 486 (03) : 184 - 187
  • [4] Thiol protein groups correlate with cognitive impairment in patients with recurrent depressive disorder
    Galecki, Piotr
    Talarowska, Monika
    Bobinska, Kinga
    Kowalczyk, Edward
    Galecka, Elzbieta
    Lewinski, Andrzej
    [J]. NEUROENDOCRINOLOGY LETTERS, 2013, 34 (08) : 780 - 786
  • [5] Total Antioxidant Status Correlates with Cognitive Impairment in Patients with Recurrent Depressive Disorder
    Monika Talarowska
    Piotr Gałecki
    Michael Maes
    Kinga Bobińska
    Edward Kowalczyk
    [J]. Neurochemical Research, 2012, 37 : 1761 - 1767
  • [6] ASMT gene expression correlates with cognitive impairment in patients with recurrent depressive disorder
    Talarowska, Monika
    Szemraj, Janusz
    Zajaczkowska, Marlena
    Galecki, Piotr
    [J]. MEDICAL SCIENCE MONITOR, 2014, 20 : 905 - 912
  • [7] Total Antioxidant Status Correlates with Cognitive Impairment in Patients with Recurrent Depressive Disorder
    Talarowska, Monika
    Galecki, Piotr
    Maes, Michael
    Bobinska, Kinga
    Kowalczyk, Edward
    [J]. NEUROCHEMICAL RESEARCH, 2012, 37 (08) : 1761 - 1767
  • [8] iNOS gene expression correlates with cognitive impairment in recurrent depressive disorder
    Talarowska, M.
    Galecki, P.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S327 - S328
  • [9] Malondialdehyde plasma concentration correlates with declarative and working memory in patients with recurrent depressive disorder
    Monika Talarowska
    Piotr Gałecki
    Michael Maes
    Ann Gardner
    Marcelina Chamielec
    Agata Orzechowska
    Kinga Bobińska
    Edward Kowalczyk
    [J]. Molecular Biology Reports, 2012, 39 : 5359 - 5366
  • [10] Malondialdehyde plasma concentration correlates with declarative and working memory in patients with recurrent depressive disorder
    Talarowska, Monika
    Galecki, Piotr
    Maes, Michael
    Gardner, Ann
    Chamielec, Marcelina
    Orzechowska, Agata
    Bobinska, Kinga
    Kowalczyk, Edward
    [J]. MOLECULAR BIOLOGY REPORTS, 2012, 39 (05) : 5359 - 5366